These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1947759)
1. Tumour markers--an update. Proceedings from the first meeting on tumour markers. Trondheim, 24-25 May 1991. Scand J Clin Lab Invest Suppl; 1991; 206():5-105. PubMed ID: 1947759 [No Abstract] [Full Text] [Related]
2. Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt? Tuzun Y; Celik Y; Bayan K; Yilmaz S; Dursun M; Canoruc F J Int Med Res; 2009; 37(1):79-86. PubMed ID: 19215676 [TBL] [Abstract][Full Text] [Related]
3. [What importance do tumor markers have in life insurance medicine?]. Binsack T; Kraus HK Versicherungsmedizin; 1990 Dec; 42(6):157-62. PubMed ID: 2291265 [TBL] [Abstract][Full Text] [Related]
4. The role of established tumour markers. van Dalen A Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():527-8. PubMed ID: 1958061 [No Abstract] [Full Text] [Related]
5. The use and potential of serum tumour markers, new and old. Bates SE Drugs; 1989 Jul; 38(1):9-18. PubMed ID: 2670513 [No Abstract] [Full Text] [Related]
7. A review of the role of established tumour markers. Beastall GH; Cook B; Rustin GJ; Jennings J Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():5-18. PubMed ID: 2024935 [TBL] [Abstract][Full Text] [Related]
8. Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers. Wang HY; Hsieh CH; Wen CN; Wen YH; Chen CH; Lu JJ PLoS One; 2016; 11(6):e0158285. PubMed ID: 27355357 [TBL] [Abstract][Full Text] [Related]
9. Abstracts of the 3rd EORTC-NCI International Meeting on Cancer Molecular Markers. April 18-20, 2004, Brussels, Belgium. Int J Biol Markers; 2004; 19 Suppl 3():S7-59. PubMed ID: 15129678 [No Abstract] [Full Text] [Related]
10. Proceedings of a Workshop on the Biochemical and Immunologic Diagnosis of Cancer. Tumour Biol; 1987; 8(2-3):58-180. PubMed ID: 3448765 [No Abstract] [Full Text] [Related]
11. Clinical evaluation of tumor-associated trypsin inhibitor (TATI). Proceedings of a symposium. Barcelona, September 24, 1989. Scand J Clin Lab Invest Suppl; 1991; 207():1-73. PubMed ID: 1685801 [No Abstract] [Full Text] [Related]
12. Some developments with tumour markers [proceedings]. Bagshawe KD Arzneimittelforschung; 1979; 29(2):355-6. PubMed ID: 582150 [No Abstract] [Full Text] [Related]
13. Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfalls. Gion M; Daidone MG Eur J Cancer; 2004 Nov; 40(17):2613-22. PubMed ID: 15541962 [TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers. Gregory JJ; Finlay JL Drugs; 1999 Apr; 57(4):463-7. PubMed ID: 10235686 [TBL] [Abstract][Full Text] [Related]
15. The Role of CTCs as Tumor Biomarkers. Lianidou ES; Markou A; Strati A Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology. Strijbos MH Acta Clin Belg; 2011; 66(5):332-6. PubMed ID: 22145267 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in tumour diagnosis--who actually needs it? Pervez S J Pak Med Assoc; 1994 Aug; 44(8):199. PubMed ID: 7996670 [No Abstract] [Full Text] [Related]
18. [Uses of biological markers in the research and diagnosis of neoplasms]. Yuan M Zhonghua Bing Li Xue Za Zhi; 1993 Oct; 22(5):307-9. PubMed ID: 8168200 [No Abstract] [Full Text] [Related]
19. Reaching agreement on tumor markers. Check W CAP Today; 1998 Jul; 12(7):1, 34, 38 passim. PubMed ID: 10181878 [No Abstract] [Full Text] [Related]
20. Serum tumor markers: past, state of the art, and future. Thomas CM; Sweep CG Int J Biol Markers; 2001; 16(2):73-86. PubMed ID: 11471900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]